FOLFIRI-cetuximab regimen

{
  "id": "MLC-T-ONC-003291",
  "term": "FOLFIRI-cetuximab regimen",
  "field": "Oncology and biomedicine",
  "definitions": [
    "A chemotherapy combination used to treat a certain type of colorectal cancer that has spread to other parts of the body. It includes the drugs leucovorin calcium (folinic acid), fluorouracil, irinotecan hydrochloride, and cetuximab. Also called FOLFIRI-cetuximab.",
    "A chemoimmunotherapy regimen consisting of leucovorin (folinic acid), 5-fluorouracil, and irinotecan plus cetuximab used for the treatment of metastatic colorectal cancer that is positive for the expression of the epidermal growth factor receptor (EGFR) and the wild-type form of KRAS."
  ],
  "synonyms": [
    "FOLFIRI-cetuximab",
    "FOLFIRI-Erbitux regimen",
    "leucovorin-fluorouracil-irinotecan-cetuximab regimen"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/folfiri-cetuximab-regimen/"
}